ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kenneth M. Taylor
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zindrou, D.
Right arrow Articles by Bagger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zindrou, D.
Right arrow Articles by Bagger, J. P.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2002;74:2121-2125
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Excess coronary artery bypass graft mortality among women with hypothyroidism

Dlear Zindrou, MDa, Kenneth M. Taylor, MDa, Jens Peder Bagger, MDa*

a Cardiothoracic Directorate, Hammersmith Hospital, and Faculty of Medicine, Imperial College School of Science, Technology, and Medicine, London, England, UK

Accepted for publication July 22, 2002.

* Address reprint requests to Dr Bagger, Cardiothoracic Directorate, Hammersmith Hospital, Du Cane Rd, London W12 0NN, England United Kingdom.
e-mail: p.bagger{at}ic.ac.uk

BACKGROUND: The impact of thyroid disease on patients undergoing coronary artery bypass grafting has been reported in only small series of selected patients.

METHODS: We investigated 30-day mortality of patients on thyroxine replacement therapy undergoing isolated coronary artery bypass grafting from 1993 to 2000 and identified variables of importance for outcome.

RESULTS: A total of 3,631 patients (606 women) had isolated coronary artery bypass grafting of whom 58 patients (30 women) were treated for hypothyroidism. The mortality rate was higher among women with thyroxine replacement (16.7%, 95% confidence interval [CI] 5.6 to 34.7) than those without thyroxine replacement (5.9%, 95% CI 4.1 to 8.2; p = 0.02) and no difference between men with (3.6%, 95% CI 0.1 to 17.8) and without (2.6%, 95% CI 2.0 to 3.2) thyroxine treatment (p = 0.8). Intake of diuretics (p < 0.001) was directly associated with mortality whereas intake of aspirin (p = 0.01), levothyroxine dose (p = 0.03), and serum thyroxine level (p = 0.01) were inversely associated with mortality among women on thyroxine replacement.

CONCLUSIONS: Women on thyroxine replacement therapy undergoing coronary artery bypass grafting had an increased mortality rate. We speculate that insufficient thyroid hormone replacement could partly play a role in this outcome.




This article has been cited by other articles:


Home page
J EndocrinolHome page
K Boelaert and J A Franklyn
Thyroid hormone in health and disease
J. Endocrinol., October 1, 2005; 187(1): 1 - 15.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. H. Edwards, V. A. Ferraris, D. M. Shahian, E. Peterson, A. P. Furnary, C. K. Haan, and C. R. Bridges
Gender-Specific Practice Guidelines for Coronary Artery Bypass Surgery: Perioperative Management
Ann. Thorac. Surg., June 1, 2005; 79(6): 2189 - 2194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.